ACTINIUM PHARMACEUTICALS, INC. Other Restricted Assets, Current
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Other Restricted Assets, Current of $307.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:OtherRestrictedAssetsCurrent · last filed 2023-08-14
- 2023-06-30: Other Restricted Assets, Current $307.00K.
- 2023-03-31: Other Restricted Assets, Current $304.00K.
- 2022-12-31: Other Restricted Assets, Current $302.00K.
- 2022-09-30: Other Restricted Assets, Current $300.00K.
| Period end | Other Restricted Assets, Current | Other Restricted Assets, Current as first filed |
|---|---|---|
| 2023-06-30 | $307.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $304.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $302.00K 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $392.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $392.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $392.00K 10-Q · filed 2022-08-12 | |
| 2021-09-30 | $392.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $392.00K 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $392.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $391.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $391.00K 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $391.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $391.00K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $391.00K 10-K · filed 2021-03-31 | $391.33K 10-K · filed 2020-05-08 |
| 2019-09-30 | $391.18K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $391.18K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $391.18K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $391.13K 10-K · filed 2020-05-08 | |
| 2018-09-30 | $390.94K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $390.94K 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $390.94K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $390.87K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |